IMNN

Imunon Inc

• TipRanks·4h ago

  Imunon announces IDMC recommends continued Phase 2 development of IMNN-001

• TipRanks·09/10 13:40

  Imunon enters CRADA with National Cancer Institute for IMNN-001 development

• TipRanks·08/23 00:29

  Imunon Earnings Call Highlights Survival Gains, Cash Needs

• TipRanks·08/12 17:15

  Imunon: Buy Rating Reiterated as Phase 3 IMNN-001 Progress and Extended Cash Runway Support Unchanged $10 Price Target

• NASDAQ·08/12 02:12

  Imunon (IMNN) Q2 2026 Earnings Call Transcript

• TipRanks·08/11 21:33

  Imunon Adopts New Equity-Based Executive Compensation Program

• NASDAQ·08/11 18:51

  IMUNON Advances OVATION 3 Trial Of IMNN-001; Enrollment Expected To Complete In 1H29

• Seeking Alpha·08/11 12:03

  Imunon GAAP EPS of -$0.54 beats by $0.50

• Seeking Alpha·08/10 22:00

  Here are the major earnings before the open Tuesday

• Seeking Alpha·08/03 16:34

  Imunon Q2 2026 Earnings Preview

• TipRanks·07/30 13:22

  Imunon provides update on OVATION 3 trial of IMNN-001

• NASDAQ·07/21 15:40

  IMUNON Phase 2 Data Show IMNN-001 Improves MRD Outcomes In Ovarian Cancer

• TipRanks·07/21 13:25

  Imunon announces new preliminary data from IMNN-001 trial

• Seeking Alpha·07/01 04:38

  IMUNON announces executive transition: Josh Blacher appointed interim CFO as Jeffrey Church retires

• TipRanks·06/30 22:25

  Imunon interim CFO Jeffrey Church to retire, Josh Blacher to succeed